Someone is showing what it'd be like if male scientists were written about like women
"A devout husband and father, Darwin balanced his family duties with the study of the specimens he brought from his travels."
Send us a link
"A devout husband and father, Darwin balanced his family duties with the study of the specimens he brought from his travels."
Respondents value recognition initiatives related to receiving feedback from the journal over monetary rewards and payment in kind.
Corporate boards, the US Congress, and global gatherings like the just-wrapped WEF in Davos are all built on a simple theory of problem solving: Get enough smart and powerful people in a room and they'll figure it out. This may be misguided.
Growth in scientific publishing as a barrier to science communication.
In the face of routine rejection, many scientists must learn to cope with the insidious beast that is impostor syndrome.
Big US report documents increases in international collaboration and Chinese science output.
A wealth of opinions describing what remains to be done to resolve gender issues.
The Chair and Secretary-General of LERU present the signatures to the LERU Statement on Open Access to Commissioner Carlos Moedas and Dutch Secretary of State Sander Dekker.
The Montreal Neurological Institute plans to free up its findings, including data that point to connections between brain regions communicating at different neural rhythms.
Eric Lander's CRISPR history could determine the outcome of a bitter patent fight, but the author failed to disclose conflicts of interest, critics say.
Stephan Lewandowsky and Dorothy Bishop explain how the research community should protect its members from harassment, while encouraging the openness that has become essential to science.
It may not be sexy, but quality assurance is becoming a crucial part of lab life.
Publishing an open-access paper in a journal can be prohibitively expensive. Some researchers are drumming up support for a movement to change that.
Response to the recommendations of an external High Level Expert Group and a Staff Working Document in which the Commission services have evaluated FP7.
A broad base of quantitative information on the U.S. and international science and engineering enterprise.
By 2025, all scholarly publication activity in Austria should be Open Access: the final versions of all scholarly publications resulting from the support of public resources must be freely accessible on the Internet without delay (Gold Open Access).
Rejection rates in Frontiers journals are around ~27%, most manuscripts are published within 3 months, and yet, Frontiers’ citations rates are amongst the very highest.
One of the strongest beliefs in scholarly publishing is that journals seeking a high impact factor should be highly selective. There is evidence showing this is wrong.
Authors tend to attribute manuscript acceptance to their own ability to write quality papers and simultaneously to blame rejections on negative bias in peer review, displaying a self-serving attributional bias.
This paper highlights key guidelines to help authors increase their data’s reuse potential and compliance with journal data policies.
This paper presents Wikiometrics: the derivation of metrics and indicators from Wikipedia.
Scientists who submit grant applications to the NIH will be required to explain the scientific premise behind their proposals and defend the quality of their experimental designs.
The design of clinical studies whose results are published in high-impact medical journals is not associated with the likelihood or amount of ensuing news coverage.
ERC funds 135 Proof of Concept grants, a press release.
A new initiative published this week outlines how scientists can make a change to open science practices at an individual level.
In an open letter some of the largest academic publishers and scientific societies are announcing that they will not just encourage, but ultimately require, researchers to sign up with ORCID.
Pathogens & Immunity promises a quick submission procedure, since it provides a reasonable flexibility about the length of the papers and authors are welcome to include reviews from other journals and their responses.
Analysis of seven prominent medical journals finds randomised controlled trials are far less likely to receive a press release than weaker observational studies.
Two NEJM editors say data sharing should happen symbiotically, not parasitically.